State Street Exits INOVIO PHARMACEUTICALS Stake
Ticker: INO · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1055726
| Field | Detail |
|---|---|
| Company | Inovio Pharmaceuticals, INC. (INO) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | medium |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: institutional-ownership, exit-filing, share-reduction
TL;DR
**State Street just dumped its Inovio shares, watch out!**
AI Summary
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 22, 2024, indicating its ownership of INOVIO PHARMACEUTICALS, INC. common stock as of December 31, 2023. This filing is an 'exit filing,' meaning State Street Corp no longer holds a reportable ownership stake (above 5%) in Inovio. This matters to investors because a large institutional investor has significantly reduced or eliminated its position, which could signal a lack of confidence or a reallocation of assets away from Inovio.
Why It Matters
When a major institutional investor like State Street Corp reduces its stake below the reporting threshold, it can be interpreted as a bearish signal, potentially influencing other investors' perceptions and the stock's price.
Risk Assessment
Risk Level: medium — The exit of a large institutional holder like State Street Corp could indicate a negative outlook on Inovio's future prospects, posing a medium risk to current and potential investors.
Analyst Insight
A smart investor would view State Street's exit as a potential red flag and conduct further due diligence into INOVIO PHARMACEUTICALS, INC.'s fundamentals and recent news before making any investment decisions, especially considering a potential lack of institutional confidence.
Key Players & Entities
- State Street Corp (company) — the institutional investor filing the SC 13G/A
- INOVIO PHARMACEUTICALS, INC. (company) — the subject company whose common stock was held
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- INOVIO PHARMACEUTICALS, INC. stock price may experience downward pressure. (INOVIO PHARMACEUTICALS, INC.) — medium confidence, target: Q1 2024
- Other institutional investors may re-evaluate their positions in INOVIO PHARMACEUTICALS, INC. (INOVIO PHARMACEUTICALS, INC.) — medium confidence, target: Q1 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934'.
Who is the 'subject company' in this filing?
The 'subject company' is INOVIO PHARMACEUTICALS, INC., as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.'.
Who is the 'filer' of this document?
The 'filer' of this document is STATE STREET CORP, as indicated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: STATE STREET CORP'.
What was the 'date of event which requires filing of this statement'?
The 'date of event which requires filing of this statement' was 12/31/2023, as explicitly stated in the filing.
What does 'EXIT FILING' mean in the context of this SC 13G/A?
'EXIT FILING' means that State Street Corp no longer holds a reportable ownership stake (typically below 5%) in INOVIO PHARMACEUTICALS INC, and this filing serves to update their previous disclosure to reflect that change.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding INOVIO PHARMACEUTICALS, INC. (INO).